Description

Regavirumab is a high-purity monoclonal antibody for pharmaceutical research and development. This compound is critical for targeted therapeutic applications, offering specificity and efficacy in advanced treatment protocols. It is primarily utilized by biotechnology firms, pharmaceutical manufacturers, and academic research institutions engaged in immunology and oncology studies.

Application

• Primary active pharmaceutical ingredient (API) in targeted biologic drug formulations.
• Key reagent in immunology research for studying specific antigen-antibody interactions.
• Critical component in the development of novel oncology therapeutics and combination therapies.
• Used in bioanalytical method development and validation for pharmacokinetic studies.
• Reference standard for quality control and regulatory compliance in biopharmaceutical manufacturing.
• Essential material for pre-clinical and clinical trial material (CTM) production.

Basic Information

Product Name	Regavirumab
CAS No.	153101-26-9
Molecular Formula	Contact for details
Molecular Weight	Contact for details
Synonyms	Anti-[Target] Monoclonal Antibody; mAb Regavirumab; Immunoglobulin G1, anti-(human [target]); Therapeutic Monoclonal Antibody; [Target]-specific mAb; Biologic API; Recombinant Humanized IgG1 kappa
EINECS	Contact for details

Quality Control

Our Regavirumab is manufactured under strict quality systems. Each batch is subjected to a comprehensive battery of analytical tests to ensure identity, purity, potency, and safety, aligning with ICH Q6B guidelines for biotechnological products. Certificates of Analysis (COA) detailing specifications and test results are provided with each shipment.

Storage

Preserve in a tightly closed container, protected from light. Store at 2-8°C. Do not freeze. This product is hygroscopic (moisture-sensitive). For long-term storage, consider aliquoting to avoid repeated freeze-thaw cycles.

Specification

Item	Specification
Appearance	Clear to slightly opalescent, colorless to pale yellow liquid
Identification (HPLC/CE-SDS)	Conforms to reference standard
Purity (SEC-HPLC)	≥ 98.0% (Monomer)
Protein Concentration	As per COA (typically 5-20 mg/mL)
Potency (Cell-based assay)	≥ 90% relative potency
Endotoxin (LAL)	< 1.0 EU/mg
Host Cell Protein (HCP)	< 100 ppm
Host Cell DNA	< 10 pg/mg
pH	6.0 - 7.5

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.